Apoptosis signal-regulating kinase 1 is associated with the effect of claudin-6 in breast cancer

Diagnostic Pathology

Chengshi Quan²  Yunpeng Liu¹  Yan Lu²  Yuanyuan Liu²  Min Wang²  Liping Wang²  Xiaowei Zhang²  Ting Zhang²  Zhijing Liu²  Xiaoming Xu³  Yaxiong Guo² 

[1] Department of Thoracic Surgery, The First Bethune Hospital of Jilin University, Jilin University, Changchun, Jilin, China;The Key Laboratory of Pathobiology, Ministry of Education, Beyuthune Medical College, Jilin University, Changchun, Jilin, China;Department of Pathology, The 2nd Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

关键词: Tight junction;    Apoptosis;    ASK1;    Breast invasive ductal carcinomas;   

Others  :  807981
DOI  :  10.1186/1746-1596-7-111

 received in 2012-07-12, accepted in 2012-08-20,  发布年份 2012

【 摘 要 】

Background

Previous studies have demonstrated that claudin-6 functions as a cancer suppressor in human MCF-7 breast cancer cells. The growth inhibitory effect could be attributed to inhibition of cell proliferation and induction of apoptosis. The purpose of the current study was to examine the involvement of apoptosis signal-regulating kinase 1 (ASK1) in the anticancer effect of claudin-6.

Methods

Immunohistochemical analysis was performed to evaluate the ASK1 protein expression and the correlation between ASK1, claudin-6 and clinicopathological features in 85 samples of breast invasive ductal carcinomas (IDC). Western blotting and RT-PCR was carried out to examine the expression of ASK1 and claudin-6 in MCF-7 cell clones transfected with claudin-6.

Results

Immunohistochemical analysis showed that ASK1 expression was significantly related with that of claudin-6 in breast invasive ductal carcinomas (P < 0.05). In addition, a positive correlation between ASK1 and C-erb B 2 protein expression was identified (P < 0.05). Western blotting and RT-PCR consistently revealed that the level of ASK1 protein and mRNA was upregulated in MCF-7 cell clones transfected with claudin-6.

Conclusions

Our data suggests, for the first time, that the ASK1 signal may play a positive role in the inhibitory effect of claudin-6 in breast cancer.

Virtual Slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1200314318763661 webcite

【 授权许可】

   
2012 Guo et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Pagani O, Senkus E, Wood W, Colleoni M, Cufer T, Kyriakides S, Costa A, Winer EP, Cardoso F: International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst 2010, 102:456-463.
• [2]Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000, 60:6281-6287.
• [3]Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003, 22:2021-2033.
• [4]Tsukita S, Furuse M, Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001, 2:285-293.
• [5]Matter K, Balda MS: Signaling to and from tight junctions. Nat Rev Mol Cell Biol 2003, 4:225-236.
• [6]Tsukita S, Furuse M: Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 1999, 9:268-273.
• [7]Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, Tamura A, Igarashi M, Endo T, Takeuchi K, Tsukita S: Predicted expansion of the claudin multigene family. FEBS Lett 2011, 585:606-612.
• [8]Turksen K, Troy TC: Barriers built on claudins. J Cell Sci 2004, 117:2435-2447.
• [9]Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE: Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 2004, 18:511-518.
• [10]Tzelepi VN, Tsamandas AC, Vlotinou HD, Vagianos CE, Scopa CD: Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms. Mod Pathol 2007, 21:22-30.
• [11]Ikari A, Sato T, Watanabe R, Yamazaki Y, Sugatani J: Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells. Biochim Biophys Acta 2012, 1823:1110-1118.
• [12]Gong Y, Renigunta V, Himmerkus N, Zhang J, Renigunta A, Bleich M, Hou J: Claudin-14 regulates renal Ca(+)(+) transport in response to CaSR signaling via a novel microRNA pathway. EMBO J 2012, 31:1999-2012.
• [13]Chiba K, Kondo Y, Yamaguchi K, Miyake H, Fujisawa M: Inhibition of Claudin-11 and Occludin Expression in Rat Sertoli Cells by Mono-(2-Ethylhexyl) Phthalate Through p44/42 Mitogen-Activated Protein Kinase Pathway. J Androl 2012, 33:368-374.
• [14]Lu Z, Ding L, Hong H, Hoggard J, Lu Q, Chen YH: Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway. Exp Cell Res 2011, 317:1935-1946.
• [15]Peter Y, Goodenough D: Claudins. Current biology: CB 2004, 14:R293-R294.
• [16]Carrozzino F, Pugnale P, Féraille E, Montesano R: Inhibition of basal p38 or JNK activity enhances epithelial barrier function through differential modulation of claudin expression. Am J Physiol Cell Physiol 2009, 297:C775-C787.
• [17]Oshima T, Miwa H, Joh T: Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. Am J Physiol Cell Physiol 2008, 295:C800-C806.
• [18]Ichijo H, Nishida E, Irie K, Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997, 275:90.
• [19]Choi HK, Chung KC: Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death. Exp neurobiol 2011, 20:35-44.
• [20]Quan C, Lu SJ: Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays. Carcinogenesis 2003, 24:1593-1599.
• [21]Osanai M, Murata M, Chiba H, Kojima T, Sawada N: Epigenetic silencing of claudin‐6 promotes anchorage‐independent growth of breast carcinoma cells. Cancer Sci 2007, 98:1557-1562.
• [22]Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y, Quan C: Tight junction protein, claudin-6, down regulates the malignant phenotype of breast carcinoma. Eur J Cancer Prev 2010, 19:186-194.
• [23]Won M, Park KA, Byun HS, Sohn KC, Kim YR, Jeon J, Hong JH, Park J, Seok JH, Kim JM, et al.: Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. Cell Death Differ 2010, 17:1830-1841.
• [24]Xu X, Jin H, Liu Y, Liu L, Wu Q, Guo Y, Yu L, Liu Z, Zhang T, Zhang X, et al.: The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas. Diagn Pathol 2012, 7:33. BioMed Central Full Text
• [25]Yafang L, Qiong W, Yue R, Xiaoming X, Lina Y, Mingzi Z, Ting Z, Yulin L, Chengshi Q: Role of Estrogen Receptor-alpha in the Regulation of Claudin-6 Expression in Breast Cancer Cells. J breast cancer 2011, 14:20-27.
• [26]Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H: Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998, 17:2596-2606.
• [27]Hatai T, Matsuzawa A, Inoshita S, Mochida Y, Kuroda T, Sakamaki K, Kuida K, Yonehara S, Ichijo H, Takeda K: Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J Biol Chem 2000, 275:26576-26581.
• [28]Takeda K, Matsuzawa A, Nishitoh H, Tobiume K, Kishida S, Ninomiya-Tsuji J, Matsumoto K, Ichijo H: Involvement of ASK1 in Ca2+-induced p38 MAP kinase activation. EMBO Rep 2004, 5:161-166.
• [29]Noguchi T, Takeda K, Matsuzawa A, Saegusa K, Nakano H, Gohda J, Inoue J, Ichijo H: Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death. J Biol Chem 2005, 280:37033.
• [30]Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D: Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 1998, 281:1860-1863.
• [31]Morgan M, Thorburn J, Pandolfi PP, Thorburn A: Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. J Cell Biol 2002, 157:975-984.
• [32]Zhang R, Zhang H, Lin Y, Li J, Pober JS, Min W: RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation. J Biol Chem 2007, 282:14788-14796.
• [33]Juric V, Chen CC, Lau LF: TNFalpha-induced apoptosis enabled by CCN1/CYR61: pathways of reactive oxygen species generation and cytochrome c release. PLoS One 2012, 7:e31303.
• [34]Zhang R, Luo D, Miao R, Bai L, Ge Q, Sessa WC, Min W: Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. Oncogene 2005, 24:3954-3963.
• [35]Zhang L, Chen J, Fu H: Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci U S A 1999, 96:8511-8515.